Researchers
Protecting my results
Developing my project
Involving companies
Thinking about Entrepreneurship
Pathway for Pre-Entrepreneurship of Inserm Transfert
The Pathway for Pre-Entrepreneurship Meetings
Human Health Startup Factory
Companies
An exceptional offer
A response dedicated to your requirements
Our strategic innovation domains
Investors
Inserm Transfert
Our mission and successes
Governance
Our history
Our quality policy
Careers
Technology offers
Notre vision
Postes à pourvoir
Nos expertises métiers
Paroles de collaborateurs
Contacts
Notre vision
Postes à pourvoir
Nos expertises métiers
Paroles de collaborateurs
Actualités
Notre vision
Postes à pourvoir
Nos expertises métiers
Paroles de collaborateurs
FR
FR
EN
My Account
Home
Visit our website
Contact us
News
Back to results
Cellular fibronectin toolset
Expression vectors encoding human 'cellular' fibronectin variants harboring the alternatively spliced Extra Domains B and/or A (or neither) ; fibronectin variant-expressing cells and purified recombinant cellular fibronectin variant proteins.
Read the document
Read the document
Interest / Relevance:
Cellular (also known as "oncofetal") fibronectin variants harboring one or both alternatively spliced so-called extra domains (EDB and EDA) play a central bioregulatory role during development, repair processes and fibrosis.
Keywords:
extracellular matrix, fibrosis, angiogenesis, tumor microenvironment
Scientist's name:
Ellen VAN OBBERGHEN-SCHILLING
Georgios Efthymiou
Agata Radwanska
Detailed technology overview:
Detailed technology is described in :
Efthymiou G, et al. Fibronectin Extra Domains tune cellular responses and confer topographically distinct features to fibril networks. J Cell Sci. 2021 : jcs.252957 doi: 10.1242/jcs.252957 Published 1 February 2021.
- Construction of lentiviral expression vectors harboring the alternatively-spliced « cellular FN » variants containing Extra Domain A and/or B, or no Extra Domain (plasma-like FN)
- Production of lentiviral particles for transduction of FN variant-expressing cells
- Expression of FN variants in (assembly-incompetent) HEK293 cells
- Purification of soluble FN variants secreted by FN-expressing HEK293 cells
- Expression of FN variants in assembly-competent cells
- Addition of purified FN variants to cells for functional studies
- Preparation of variant-specific « cell-derived matrices »
Reference:
RT00508
Type of research tool:
Others
Therapy area(1):
Oncology
Therapy area(2):
Cardiovascular Diseases
Uses(1):
Academic Research
Uses(2):
Industry Research (screening, tox.studies, bioreactor, ...)
Business Developper
contact
Inserm Transfert
Research Tools
Phone
E-mail
Rare disease:
Last update:
22/02/2022
You might also be interested in
View more
Informations